Search Results1-8 of  8

  • 五味 和紀 ID: 9000001294111

    国立感染研 (2001 from CiNii)

    Articles in CiNii:1

    • マクロファージによる Flavobacterium meningosepticum の膜脂質成分 Serine-Glycine-containing lipid の認識機構 (2001)
  • 五味 和紀 ID: 9000004038195

    岩手県立中央病院循環器科 (1997 from CiNii)

    Articles in CiNii:1

    • 25) 当院におけるステント植込み症例の検討 (1997)
  • 五味 和紀 ID: 9000004687189

    東北大学病院遺伝子呼吸器内科 (2006 from CiNii)

    Articles in CiNii:2

    • P7-43 高齢者非小細胞肺癌に対するカルボプラチンと少量分割パクリタキセル併用療法の第二相試験(ポスター総括7 : 内科2 Poor risk症例の化学療法) (2004)
    • 15.GefitinibによるInterstitial Lung Disease (ILD)を発症した後,再投与が有効であったEGFR変異陽性肺腺癌の1例(第45回 日本肺癌学会東北支部会,東北支部,支部活動) (2006)
  • GOMI KAZUNORI ID: 9000005267711

    東北大学大学院医学系研究科 (2001 from CiNii)

    Articles in CiNii:1

    • 結核菌は宿主の脂質を食べて生き延びる(D・生化学, 衛生化学) (2001)
  • GOMI KAZUNORI ID: 9000256799331

    Department of Respiratory Oncology and Molecular Medicine, Division of Cancer Control, Institute of Development, Aging and Cancer, Tohoku University (1999 from CiNii)

    Articles in CiNii:1

    • <I>in vitro</I> ACTIVITY OF BIAPENEM (BIPM) AGAINSTCLINICALLY ISOLATED RESPIRATORY PATHOGENS IN 1996-199 (1999)
  • GOMI Kazunori ID: 9000004445121

    Department of Respiratory Medicine, Tohoku University Graduate School of Medicine (2010 from CiNii)

    Articles in CiNii:11

    • IN VITRO ACTIVITY OF BIAPENEM(BIPM) AGAINST CLINICALLY ISOLATED RESPIRATORY PATHOGENS IN 1996~1998 (1999)
    • Sepsis caused by methicillin-resistant Staphylococcus aureus (MRSA) without effects of vancomycin (VCM), teicoplanin (TEIC) and arbekacin (ABK) treated successfully and safely with intravenous administration of linezolid (LZD) (2004)
    • Results of a survey of community-acquired-pneumonia and evaluation of old and new Japanese Respiratory Society guidelines (2007)
  • Gomi Kazunori ID: 9000256467295

    Department of Respiratory Oncology and Molecular Medicine, Institute of Development, Aging and Cancer, Tohoku University (2003 from CiNii)

    Articles in CiNii:1

    • Antimicrobial activity of NM 394, an active form of prulifloxacin, against clinical isolates of Pseudomonas aeruginosa with a type II topoisomerase mutation. (2003)
  • Gomi Kazunori ID: 9000256467543

    Respiratory Oncology and Molecular Medicine, Institution of Development, Aging and Cancer, Tohoku University (2004 from CiNii)

    Articles in CiNii:1

    • Sepsis caused by methicillin-resistant Staphylococcus aureus (MRSA) without effects of vancomycin (VCM), teicoplanin (TEIC) and arbekacin (ABK) treated successfully and safely with intravenous administration of linezolid (LZD) (2004)
Page Top